Status:
COMPLETED
Communication and Coping for Mothers of Adolescents With Type 1 Diabetes
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
University of Connecticut
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
Phase:
NA
Brief Summary
Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. Further, maternal depressive...
Detailed Description
Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. The regimen recommended for ...
Eligibility Criteria
Inclusion
- Female caregiver of an adolescent with type 1 diabetes
- Adolescent age 11-17
- Adolescent diagnosed with type 1 diabetes for at least 12 months
- Caregiver reports mild to moderate depressive symptoms (PHQ-9 score of 5-19) OR OR caregiver reports diabetes distress (Parent/Teen Relationship Distress Subscale score of 2 or higher)
- English speaking
Exclusion
- Caregiver reports minimal depressive symptoms (PHQ-9 score less than 5)
- Caregiver reports severe depressive symptoms (PHQ-9 score 20 or higher)
- Caregiver reports history of severe psychopathology (bipolar disorder or schizophrenia)
- Caregiver reports that adolescent has history of severe psychopathology (bipolar disorder or schizophrenia)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2023
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT03818711
Start Date
April 1 2019
End Date
September 2 2023
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232